Karl Uhlendorf is director of communications and stakeholder engagement at Astellas Pharma US, Inc. With a 20-year track record of leading diverse public affairs and editorial teams, he currently oversees Astellas’ government communications and stakeholder engagement program.
Prior to joining Astellas in 2014, Karl was vice president of communications and public affairs at the Pharmaceutical Research & Manufacturers of America (PhRMA), responsible for communications strategy and execution in support of the association’s federal and state advocacy priorities. During his eight years at PhRMA, he assumed roles of increasing responsibility and scope.
Prior to joining PhRMA, Karl was editorial director at FDC Reports/Elsevier Business Intelligence, publisher of “The Pink Sheet” and other leading trade publications dedicated to FDA-regulated industries. He began his career as a reporter covering biomedical research and health policy, parlaying the experience into a series of editorial leadership positions.
Karl is actively engaged with a wide array of health-related organizations, including PhRMA, the Biotechnology Innovation Organization, National Pharmaceutical Council, National Consumers League, HealthyWomen, WomenHeart, Research!America and Caregivers Action Network. He graduated with a Bachelor of Literature degree from Bates College in Lewiston, Maine.
Astellas is excited to host its second annual patient advocacy summit in Wa ...
You do not have permission to view this content. To register on the site and access all content click on Request Registration, submit your details, and a member of the Astellas stakeholder engagement team will review and create your profile.